Cigna's Express Scripts launches cost-based drug pricing model

In a move to address the rising cost of prescription drugs in the United States, Cigna (NYSE:CI)'s pharmacy benefit manager (PBM) unit, Express Scripts, announced today the launch of its new cost-based pricing program named Express Scripts ClearNetwork. The program is set to transform how PBM clients, including employers and health plans, purchase medications by offering them at wholesale costs plus a maximum fee of 15%, starting from early 2024.